Document 3138 DOCN M94A3138 TI Seronegativation in an asymptomatic HIV1 infected patient. DT 9412 AU Sousa A; Lourenco MH; Ferreira MO; Teles LC; Victorino RM; Faculdade de Medicina, Lisboa, Portugal. SO Int Conf AIDS. 1994 Aug 7-12;10(1):145 (abstract no. PB0008). Unique Identifier : AIDSLINE ICA10/94369437 AB OBJECTIVE: To report immunological and virological studies in an asymptomatic HIV infected patient in wham seronegativation was documented. METHODS: Two different ELISA methods were done as initial tests for HIV1 antibodies followed by Western blot to identify individual proteins sequentially done during the 6 years follow-up period. Flow cytometry was used for quantitation of CD3+, CD8+, CD45RO+, CD45RA+, cells in peripheral blood. Lymphocyte proliferative responses to mitogens was measured by 3H thymidine incorporation in peripheral blood mononuclear cells cultured in triplicate. Similarly responses to HIV1 and HIV2 recombinant proteins in three different concentrations (gp 120, gp 105, p 24 and p 26 provided by the MRC-U.K.) were studied using 24 replicates (24 culture wells for each concentration of protein). RESULTS: The patient was a 48 year old female who was tested for HIV in a blood bank and was found to have a clearly positive ELISA test and antibodies to all HIV1 strutural proteins on two different occasions (gp 160, gp 110, gp 41, p 24, p 18). Although the patient lived in Portugal, her sexual partner had lived long periods in Central Africa. She was referred to an HIV clinic where she was followed for 6 years. A progressive loss of antibodies to the different proteins was recorded in the sequential Western blots (first to envelope proteins and finally to core). She has presently no antibodies to any of the HIV proteins. Levels of CD4+, CD8+, CD45RO+, CD45RA+ cells were normal along the follow-up. Studies on the T helper responses to recombinant HIV1 proteins (core and envelope) will be presented. CONCLUSION: This case illustrates the possibility of seronegativation in HIV1 infection and this will be discussed considering the epidemiological data and the results of the immunological studies. DE Case Report Enzyme-Linked Immunosorbent Assay/METHODS Female Flow Cytometry Human HIV Antibodies/*BLOOD HIV Seronegativity/*IMMUNOLOGY HIV Seropositivity/*IMMUNOLOGY *HIV-1 Lymphocyte Transformation Lymphocytes/IMMUNOLOGY Middle Age T-Lymphocytes, Helper-Inducer/IMMUNOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).